) complexes have excellent luminescence properties for biological applications, i.e., long luminescence lifetime of the order of milliseconds and a large Stoke's shift of Ͼ200 nm. Their long-lived luminescence is especially suitable for time-resolved measurements, because the interference from short-lived background fluorescence and scattered light rapidly decays to a negligible level after a pulse of excitation light is applied, and the emitted light can be collected after an appropriate delay time. These luminescent lanthanide complexes have already found commercial use as highly sensitive luminescent probes in heterogeneous and homogeneous assays. This paper reviews our research on the design and synthesis of responsive lanthanide-based MRI and luminescent probes for advanced bioimaging.
Introduction
The lanthanides present various unique chemical properties that are favorable for both biological and materials research, and interest in their applications is increasing. 1, 2) Lanthanide-based probes, especially responsive lanthanide probes intended for bioassay and bioimaging, are new players in these areas, and offer many advantages over typical organic molecules. [3] [4] [5] This paper reviews our research on the development of responsive lanthanide-based magnetic resonance imaging (MRI) and luminescent probes for biological applications.
Responsive Gadolinium (Gd

3؉ )-Based MRI Contrast Agents for Bioimaging
Light-based microscope imaging techniques with fluorescent dyes are limited by photobleaching of the dyes and by light scattering by cells within 100 mm of the surface. MRI can overcome these problems, and is especially useful for imaging inside intact, opaque organisms. 6, 7) MR images are based on topological representations of NMR parameters, and their contrast is determined not only by the complex interplay of endogenous factors (T 1 , T 2 , and proton density), but also by various instrumental parameters. The contrast of MR images can be further enhanced by the use of MRI contrast agents, which act by enhancing the proton relaxation rates in the tissues to which they are distributed. Gd 3ϩ complexes, which are paramagnetic, are frequently chosen as MRI contrast agents, and these complexes enhance the T 1 (spin-lattice) and T 2 (spin-spin) relaxation rates of water protons in the proximity of the paramagnetic center, Gd 3ϩ . [8] [9] [10] In Gd 3ϩ -based MRI contrast agents, chelation of Gd 3ϩ is required for safety reasons: dissociation of Gd 3ϩ from a MRI contrast agent is undesirable, as both the free metal and unchelated ligands are generally more toxic than the complex itself, and commonly used MRI contrast agents are mainly extracellular agents with nonspecific biodistribution. However, it is possible to develop Gd 3ϩ complexes with various functions by means of appropriate ligand design for Gd 3ϩ . For example, some bioactivated MRI contrast agents, whose ability to relax water protons is greatly enhanced by recognition of a biomolecule, have been reported for monitoring of enzyme activity, Ca 2ϩ , pH, p(O 2 ), etc. [11] [12] [13] [14] [15] These MRI contrast agents induce a change in the water proton relaxation time (T 1 or T 2 ) in response to the presence of the target biomolecule.
The design of MRI contrast agents requires an understanding of the factors which determine the relaxation enhancement of the tissue protons. In an aqueous solution of Gd enhancement of the solvent water protons which are propagated to the bulk through the exchange of the water molecules dipolarly coupled to Gd 3ϩ , i.e., water molecules that are directly coordinated to Gd 3ϩ (inner sphere), those that belong to a second coordination sphere, and those that simply diffuse at the surface of the Gd 3ϩ complex (outer sphere) ( Fig.  1) . Prototropic exchange is involved in the transmission of the magnetic interaction, and this may involve water protons in the inner or second coordination sphere or other exchangeable protons on the ligand. Therefore, the contrast of MR images can be modulated by appropriate design of Gd 3ϩ complexes.
Firstly, focusing on water molecules in the inner sphere, several Gd 3ϩ -based bioactivated MRI contrast agents have been reported for monitoring enzyme activity, Ca 2ϩ , etc. 11, 12) These MRI agents showed a change in the relaxation rate in the presence of biomolecules owing to modulation of the accessibility of water molecules to the chelated Gd 3ϩ ion. For example, Meade and co-workers developed the bioactivated MRI contrast agent, EgadMe, which reports on b-galactosidase activity to image the expression of a transgene.
11) bGalactosidase is a commonly used gene expression marker, i.e., gene expression is monitored by introducing a marker gene, lacZ, to follow the regulation of a gene of interest, because it can easily be assayed and is not normally expressed in most mammalian tissues or cells. [16] [17] [18] This agent has been used to monitor gene expression in Xenopus laevis in vivo.
We also developed a novel zinc ion (Zn 2ϩ )-sensitive MRI contrast agent, the Gd 3ϩ diethylenetriaminepentaacetic acid (DTPA) bisamide complex 1 (Fig. 2) . 19) Zn 2ϩ is the second most abundant heavy metal ion after iron in the human body, and it is also an essential component of many enzymes, transcription factors, and synaptic vesicles in excitatory nerve terminals. [20] [21] [22] Recently, Zn 2ϩ has been reported to play important roles in regulating synaptic transmission and cell death. 23 . 24, 25) In characterizing 1, we observed that the water proton r 1 relaxivity of 1 showed an unusual Zn 2ϩ dependence (Fig. 3) . The longitudinal relaxivity value r 1 refers to the amount of increase in 1/T 1 per millimolar concentration of agent (often given as per mM Gd).
6) The observed longitudinal relaxation rate (1/T 1 ) obs of the solvent water protons is known to depend on the con- The propagation of the paramagnetic effect may occur through (i) exchange of the inner-sphere water protons; (ii) exchange of water molecules hydrogen-bonded at the Gd 3ϩ complex surface and exchange of mobile hydrogens on the ligand; (iii) diffusion around the Gd 3ϩ complex of the outer-sphere water molecules. (
where ( ] would give the r 1 relaxivity as the slope, and the r 1 relaxivity, normally expressed in units of mM Ϫ1 s
Ϫ1
, reflects the relaxation enhancement ability of the Gd 3ϩ complex. The r 1 relaxivity of a solution of 1 decreased dose-dependently between 0 and 1.0 eq Zn 2+ , reaching a minimum at 1.0 eq Zn 2ϩ to 1, and then increasing dose-dependently between 1.0 and 2.0 eq. The r 1 relaxivity of 1 decreased approximately 33% when Zn 2ϩ (1.0 eq to 1) was added to a Zn 2ϩ -free solution. The change in T 1 generated by the addition of Zn 2ϩ (1.0 eq to 1) can be visualized in MR images of a solution of 1 (Fig. 4) . This hypothesis was supported by measurements of the UV-visible spectra and the coldspray ionization (CSI) mass spectra. [26] [27] [28] Thus, these Zn 2ϩ -chelating characteristics of 1 seem to modulate access of water molecules to the Gd 3ϩ ion. However, the behavior of the r 1 relaxivity of a solution of 1 is problematic, because the response above 1.0 eq of Zn 2ϩ is also augmented and hence not monotonic. Briefly, for example, one cannot distinguish the r 1 values of solutions of 1 containing 0.3 and 1.5 eq of Zn 2ϩ . The amides of compound 1 have relatively weak chelating ability, and moreover, we hypothesized that compound 1 would suffer from a steric repulsion effect of the four pyridines in the Zn 2ϩ -1 1 : 1 complex (Fig. 2) . Therefore, we designed and synthesized the Gd 3ϩ DTPA-bisamide complex 2, which is a derivative of 1, as a novel Zn 2ϩ -sensitive MRI contrast agent (Fig. 5) . 29) The reasoning behind the design of 2 is as follows. The carboxylate substituent chelates Zn 2ϩ strongly, and has a smaller steric repulsion than pyridyl. So, we expected to obtain a monotonic change with this stronger chelator. Indeed, in characterizing 2, we observed that the water proton r 1 relaxivity of a solution of 2 had a monotonic Zn 2ϩ dependence (Fig. 6 ). The r 1 relaxivity decreased dose- . These characteristics of the complex are favorable for in vivo imaging of Zn 2ϩ concentration changes by comparing the signal intensity decreases in a region of interest with and without various stimuli, given that the clearance of the agent itself should remain unchanged. These agents (1, 2) are the first Zn 2ϩ -sensitive MRI contrast agents, and should be excellent candidates for incorporation into sensors designed for biological applications. Indeed, several Zn 2ϩ -sensitive MRI contrast agents have recently been reported. [30] [31] [32] Secondly, another possible approach for the development of responsive MRI contrast agents is the RIME (receptor-induced magnetization enhancement) approach. [33] [34] [35] The binding of a MRI contrast agent to a macromolecule substantially slows molecular rotation of the Gd 3ϩ complex, resulting in an additional increase in the r 1 relaxivity through the rotational correlation time t R . 7) In other words, when the Gd 3ϩ complex binds to a macromolecule, the t R increases from that of a small molecule to that of the protein, and the r 1 relaxivity increases. The slower the Gd 3ϩ complex tumbles, the longer the t R , leading to faster relaxation rates and hence higher r 1 relaxivity. The length of t R for small Gd 3ϩ complexes is usually in the picosecond range (typically 50-200 ps), whereas the t R for a macromolecule such as albumin is in the nanosecond range (ca. 50 ns). 36) This phenomenon is known as RIME, and RIME agents have been reported for alkaline phosphatase and for carboxypeptidase B (part of the thrombin-activatable fibrinolysis inhibitor family), which regulate noncovalent binding of the agents to human serum albumin (HSA). 37, 38) Another agent permitted the detection of yeast transcription repressor protein (Gal80) in MR images by utilizing a specific peptide-protein binding event, 39) and efficient polymerization of Gd 3ϩ complexes was also used to image the activity of myeloperoxidase (MPO). 40) We developed a novel b-galactosidase-activated MRI contrast agent 3, which is a Gd 3ϩ complex, by using the RIME approach (Fig. 8) . 41) Compound 3 is composed of three moieties: 1) a masking group consisting of galactopyranose; 2) an albumin-binding moiety, the biphenyl group; 3) a MRI signal-generating moiety, which is a Gd 3ϩ complex. The biphenyl group was selected as the albumin-binding group, because the biphenyl residue is known to possess high albumin binding affinity. 6, 38, 42) A substrate for b-galactosidase, galactopyranose, was used as a masking group, affording high hydrophilicity compared with the hydrophobicity of the biphenyl group. i.e., cleavage of the galactopyranose moiety from the aryl group of the Gd 3ϩ complex increases the hydrophobicity of the aryl group, thereby increasing the HSA binding affinity. The greater binding of the Gd 3ϩ complex to the macromolecule, HSA, increases the r 1 relaxivity. Thus, the Gd 3ϩ complex 3 was designed to detect b-galactosidase activity through its conversion into 4 ( In compound 3, a Gd 3ϩ complex is coupled to an albumin binding moiety that is masked by the galactopyranose residue. The galactopyranose residue of 3 is designed to be cleaved by b-galactosidase, transforming 3 to 4, and this cleavage promotes albumin binding of the Gd 3ϩ complex. galactosidase, while the value of 1/T 1 changed only slightly from 3.8 to 4.0 s Ϫ1 between 0 and 250 min on exposure to heat-inactivated b-galactosidase. On HPLC analysis, the Gd 3ϩ complexes, 3 and 4, showed distinct retention times, and it was confirmed that 3 was converted into 4 in the presence of b-galactosidase, while essentially no change was observed upon the addition of heat-inactivated b-galactosidase. Thus, compound 3 exhibited a b-galactosidase-induced RIME effect, accompanying the removal of the galactopyranose residue of 3.
Thirdly, it is also possible to modulate prototropic exchange by utilizing pendant arms of ligands. Sherry and coworkers have developed a pH-sensitive MRI contrast agent, which has the tetraamide-based ligand with extended phosphonate side chains with the intention of generating systems with specific ion-pairing capability. 13) In characterizing this MRI contrast agent, it was observed that the water proton r 1 relaxivity of the compound showed an unusual pH dependence, increasing between pH 4 and 6, reaching a maximum near pH 6, gradually decreasing to a minimum near pH 8.5, and then remaining relatively insensitive to pH 10.5 before increasing once again at higher pH values.
Future Challenges for Low-Molecular-Weight Gd 3؉ Complexes As mentioned above, MRI has become increasingly widely used for both experimental and clinical molecular imaging. However, simple low-molecular-weight Gd 3ϩ complexes such as those currently used in clinical MRI have a significant problem, i.e., they are considered too insensitive for imaging applications. 43, 44) For example, nowadays, there is great interest in the development of MRI contrast agents that can be targeted to specific biomolecules, and given the limited sensitivity of T 1 -based agents such as Gd 3ϩ complexes, a question arises as to whether or not biologically interesting molecules are present at a sufficiently high concentration to allow them to be visualized. [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] Therefore, we examined the detection limit of such Gd 3ϩ complexes in a detection system with molecules clustered together to form microdomains of high local concentration. 59) i.e., we examined how concentrations of anti-FLAG antibody could be imaged using a relatively simple, low-molecular-weight targeted contrast agent consisting of the FLAG-peptide linked to a Gd 3ϩ complex, FLAG-peptide-GdDO3A conjugate 5 (Fig. 10) . The anti-FLAG antibody had a high affinity for 5 (K d ϭ150 nM), and the water proton r 1 relaxivity of 5 (10.7 mM Ϫ1 s Ϫ1 (23 MHz, 25°C)) increased approximately 1.6 fold when 5 was bound to the antibody. The detection limits of 5 in Tris-buffered saline (TBS) buffer and on the surface of anti-FLAG agarose gel beads at 9.4 T MRI were 9 mM (ϭ9 pmol/mm 3 ) and 4 mM (ϭ4 pmol/mm 3 ), respectively, as defined for a contrast-to-noise ratio of 3 (3s). 60) Further, analytically, one can define the detection limit in terms of the smallest T 1 difference (of solvent versus solvent with agent) necessary to produce significant image contrast (Eq. 2), which in turn is proportional to [Gd 3ϩ ] DL at the detection limit times the r 1 relaxivity of the agent.
If one fixes (T 1P
) DL to the value determined experimentally, one can easily predict the lower detection limits of other Gd 3ϩ -based agents that may have even higher fully bound r 1 relaxivity values. The curve in Fig. 11 shows this prediction in graphical form. For a molecularly targeted agent consisting of a single Gd 3ϩ ion with bound r 1 relaxivity of 100 mM Ϫ1 s Ϫ1 or five Gd 3ϩ complexes each with a bound r 1 relaxivity of 20 mM Ϫ1 s
, the detection limit of a protein microdomain is approximately 690 nM using a 9.4 T spectrometer. It can be considered that cell surface receptors overexpressed on the surface of tumors might be present at a sufficiently high local concentration to be imaged by targeted low-molecular-weight Gd 3ϩ complexes if their binding affinity and specificity were sufficient to allow enough of them to be clustered in such a microdomain. 61) Thus, our results and extrapolations suggest that MRI detection using low-molecular-weight targeted T 1 agents is not an unrealistic goal, and we should consider these detection limits of Gd 3ϩ complexes in relation to the future development of in vivo responsive Gd 3ϩ -based MRI contrast agents.
Responsive Lanthanide-Based Luminescent Probes for Bioimaging
Fluorescence imaging is a powerful tool for the visualization of biomolecules in various biological environments, and is important for elucidating biological functions. 62, 63) Further, the development of new fluorescent dyes with improved photophysical properties, combined with technical progress in optical devices for fluorescence microscopy, will open the way to superior fluorescence imaging technologies. Usual time-resolved fluorescence microscopy exploits differences in fluorescence lifetimes of the order of nanoseconds to monitor target fluorescence, and this technique has been used to image interactions between proteins or protein phosphorylation by detecting fluorescence resonance energy transfer (FRET), and to report on the local environment of fluorophores, for example, local pH, refractive index, ion or oxygen concentration. 64) We have developed a new system for time-resolved long-lived luminescence microscopy (TRLLM), which utilizes the extremely long luminescence lifetimes of luminescent lanthanide complexes, of the order of milliseconds. 65) TRLLM is expected to allow imaging with complete elimination of the short-lived background fluorescence, providing high signal-to-noise ratios, by the introduction of an appropriate delay time between the pulsed excitation light and measurement of the long-lived luminescence of the dye (Fig. 12) . [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] Thus, this TRLLM imaging has very different characteristics from conventional timeresolved fluorescence imaging. A schematic of the TRLLM system, which was newly developed by us, is shown in Fig.  13 . This system utilizes a conventional fluorescence microscopy system equipped with an image intensifier (I.I.) unit, xenon flash lamp and timing controller. Applications of mechanical choppers in TRLLM with long-lived luminescent dyes have been reported by some groups, [66] [67] [68] [69] [70] [71] [72] [73] and other groups have employed an I.I. unit for the time-resolution. 74, 75) New fluorescent dyes with long fluorescence lifetimes are needed for the TRLLM-based microscopic method. Luminescent lanthanide complexes, in particular complexes of europium and terbium trivalent ions (Eu 3ϩ and Tb 3ϩ ), possess extremely long luminescence lifetimes of the order of milliseconds, whereas typical organic fluorescent compounds possess short fluorescence lifetimes in the nanosecond region. 76, 77) Further, luminescent lanthanide complexes are thought to be relatively insensitive to photobleaching and the generation of singlet oxygen compared with phosphorescent dyes. 67) For these reasons, luminescent lanthanide complexes have recently been exploited in various bioassays with time- ] at the detection limitϭ4 mM, is constant for the curve. This constant corresponds to the smallest difference in T 1 that the MRI can discriminate under these imaging conditions. The values of r 1 relaxivity at the detection limits for GdDO3A-FLAG(5)-Ab-Gel system (4.0 mM), GdDO3A-FLAG (5) in solution (9.0 mM), and the detection limit of hypothetical target agents with overall r 1 relaxivity of 100 mM Ϫ1 s
Ϫ1
are shown.
Fig. 13. Schematic Diagram of the Optical Apparatus Used for the TRLLM System
The excitation source is a xenon flash lamp. The excitation light passes through the excitation filter and is focused onto cells with dichroic mirrors. The emission light passes through the emission filter. The I.I. unit passes the long-lived luminescence to the CCD camera, controlling the delay time, the gate time, and the gain. The excitation and emission light can be easily selected by using appropriate excitation and emission filters. The image is recorded on the CCD camera, and then transferred to the computer for further processing with MetaFluor 6.1 software.
gating in the fields of medicine, biotechnology, and biological science. 78) On the other hand, the lanthanide f-f transitions have low absorbance, so a sensitizing chromophore covalently bound to the ligand is desirable for high luminescence (Fig. 14) . 79) Absorption by the chromophore results in effective population of its triplet level, and efficient intramolecular energy transfer conveys the absorbance energy of the excited chromophore to a chelated lanthanide metal ion, which becomes excited to the emission state (Fig. 15) . Therefore, proper chromophore design should afford luminescent lanthanide complexes which possess appropriate photochemical properties for TRLLM.
We examined the application of our newly synthesized luminescent Eu 3ϩ complex 6, to conventional microscopy or TRLLM of cultured living HeLa cells (Fig. 16a) .
65) The fluorescence microscope had an optical window centered at 617Ϯ37 nm for the emission due to Eu 3ϩ -based luminescence upon excitation at 360Ϯ40 nm. The Eu 3ϩ complex 6 was injected into cultured HeLa cells. In the prompt fluorescence images, the Eu 3ϩ complex-injected cells were seen, together with the Eu 3ϩ complex-noninjected cells which appeared owing to their weak autofluorescence (Fig. 16b) . In the TRLLM images, the autofluorescence from the cells, which is short-lived, was gated out, allowing the Eu 3ϩ complex-injected cells to be clearly distinguished (Fig. 16b) .
Despite the tremendous amount of work on luminescent lanthanide complexes, only a few complexes have yet been employed for TRLLM, 66, 67, 69, [71] [72] [73] [74] [75] 80, 81) and most complexes are used as labeling reagents for proteins. Therefore, we set out to develop responsive luminescent lanthanide probes. There are numerous requirements to be met by luminescent lanthanide complexes for usage in bioimaging with TRLLM, and these include kinetic stability in water, and a sensitizing chromophore unit that generates an efficient antenna effect. Firstly, we designed and synthesized the Zn 2ϩ -sensitive luminescent Tb 3ϩ and Eu 3ϩ DTPA-bisamide complexes 7 and 8 (Fig. 17) . 82) In the characterization of the new compound 7, we observed that the time-resolved emission intensity of (Fig. 15) . 2, 77) 4, 22°C) . The Job plot of the luminescence emission intensity of Tb 3ϩ for complexation between 7 and Zn 2ϩ has a maximum at a mole fraction of 0.5, which is indicative of the formation of a 1 : 1 complex. Figure 17 shows the proposed conformational change in the presence and absence of Zn 2ϩ . The light-conversion process of absorption to emission by energy transfer in compound 7 is also shown. We further investigated the mechanism of luminescence increase of 7 by measuring the effects of D 2 O and pH. We measured the luminescence emission spectra of 7 in D 2 O solution at pD 7.40 (100 mM HEPES buffer) in the presence of various concentrations of Zn 
83)
Therefore, it is unlikely that the increase of the emission intensity of 7 generated by the addition of Zn 2ϩ can be ascribed to the cessation of the PeT (photo-induced electron transfer) process, which occurs from the tertiary amine of the TPEN moiety to a pyridyl group. 84 ) Based on these results, the enhancement of the emission intensity of 7 upon Zn 2ϩ -binding appears to be the result of efficient intramolecular energy transfer from the pyridyl group to the Tb 3ϩ ion. This simple sensor switch for Zn 2ϩ , which serves as both a chromophore and Zn 2ϩ receptor, should be useful for the further development of Zn 2ϩ sensors. Furthermore, it would be desirable to move the excitation wavelength towards the visible region to reduce the phototoxicity of the excitation light for biological samples and to ensure compatibility with the optics of standard fluorescence microscopes. 65 ) Therefore, we designed and synthesized a novel Zn 2ϩ -sensitive luminescent Eu 3ϩ complex 9, with a longer excitation wavelength for biological applications, without loss of the high selectivity and high affinity for Zn 2ϩ (Fig. 18) . 85) The design of 9 was based on complexation of Eu 3ϩ -DTPA complex and a quinoline-containing TPEN-based ligand for Zn 2ϩ . The quinoline chromophore was selected as an antenna and a ligand, because quinoline has a longer excitation wavelength (Ͼ300 nm) than pyridine and can coordinate to metal ion. In the structure of 9, the quinolyl chromophore is fixed close to the Eu 3ϩ ion, allowing it to function efficiently as an antenna. Upon complexation with Zn 2ϩ , compound 9 exhibits strong, long-lived luminescence of the order of milliseconds, and it also offers a large Stoke's shift (Ͼ250 nm), high water-solubility, and high selectivity for Zn 2ϩ . i.e., complex 9 in aqueous solution was characterized by a luminescence spectrum with a delay time of 0.05 ms, and the time-resolved luminescence emission intensity of 9 increased significantly (8.5 fold) upon addition of 1.0 eq of Zn 2ϩ , with a large Stoke's shift of Ͼ250 nm (Fig. 19) . The emission intensity remained at a plateau in the presence of an excess of Zn 2ϩ . The luminescence emission displayed three bands at 579, 593, and 614 nm, corresponding to transitions from the 5 D 0 excited state to the 7 F 0 , 7 F 1 , and 7 F 2 ground states, respectively (Fig.  20) . 2, 77) The Job plot using the luminescence emission intensity of Eu 3ϩ at 614 nm for the complex of 9 and Zn 2ϩ indicated the presence of the 1 : 1 complex. The luminescence quantum yield (F ) was 0.9% before addition of Zn 2ϩ and The light-conversion process of absorption-energy transfer-emission permitted by 7 or 8 is also represented. The light-conversion process of absorption-energy transfer-emission permitted by 9 is also represented. . Therefore, it can be considered that the increase of the emission intensity caused by Zn 2ϩ addition was not due to a change in the direct interaction of water molecules with Eu 3ϩ . The luminescence emission intensity of 9 at 614 nm was examined at various pH values with excitation at 320 nm. There was almost no effect of H ϩ on the emission spectrum of 9 between pH 3.6 and 8.8 either in the presence or in the absence of Zn 2ϩ . Thus, the luminescence emission intensity of 9 is stable at around physiological pH. We believe that this pH stability of the luminescence is one of the key advantages of 9. In addition, the tertiary amine of 9 can be protonated at around pH 3.6, because tris(2-pyridylmethyl)amine (TPA) has pK a values of 6.10, 4.28, and 4.29.
83) This finding of insensitivity to lower pH means that the luminescence augmentation was not due to cessation of PeT from the tertiary amine, as was also the case for compound 7. Luminescence emission enhancement of 9 was not observed upon addition of 100 mM Na ϩ or K , which exist at high concentrations in biological systems, did not enhance the luminescence intensity of 9. To explore further the utility of the long luminescence lifetime of 9, we tested whether long-lived luminescence could be well distinguished from the short-lived background fluorescence and scattered light. Figure 21 presents the emission spectra of a solution of 9 together with 1 mM rhodamine 6G as an artificial short-lived background, without or with a time resolution process. There are three fluorescence peaks in Fig. 21a due to scattered light (300 nm), the increased fluorescence of the quinoline moiety (around 400 nm), and the fluorescence of rhodamine 6G (around 550 nm). Among them, rhodamine 6G fluorescence can directly interfere with Eu 3ϩ luminescence. However, the longlived luminescence detection of 9 was not affected at all by these three peaks. Thus, the luminescence of 9 should be largely free from experimental artifacts when measured with a time-resolution technique.
Compound 9 has a sufficiently long excitation wavelength for fluorescence microscopy, and is suitable for fluorescence microscopic measurements of Zn 2ϩ concentration in living cells. We examined the application of 9 to cultured living Both spectra were measured in 100 mM HEPES buffer containing 1 mM rhodamine 6G as a chromophore to provide artificial background fluorescence at pH 7.4 and 22°C. The emission spectra (a) were measured with a Hitachi F4500, and the time-resolved emission spectra (b) were measured using a delay time of 0.05 ms and a gate time of 1.00 ms with a Perkin-Elmer LS-50B. Bands can be assigned to (i) scattered excitation light, (ii) the fluorescence of the quinolyl chromophore of 9, (iii) the fluorescence of rhodamine 6G, and (iv) the long-lived luminescence of 9.
HeLa cells by using our TRLLM system (Fig. 22) . 65) Optical parameters were as follows: the fluorescence microscope had an optical window centered at 617Ϯ37 nm for the emission due to Eu 3ϩ -based luminescence excited at 360Ϯ40 nm. The delay time, prior to initiation of counting, and the gate time, during which counting takes place, were set at 70 ms and 808 ms, respectively. Compound 9 was injected into a single cultured HeLa cell in the central part of the field of view in Fig. 22a . A prompt increase of intracellular luminescence was induced when Zn 2ϩ (50 mM) and pyrithione (2-mercaptopyridine N-oxide, 5 mM), which is a zinc-selective ionophore, were added to the medium at 5 min (Fig. 22c) . Further, the luminescence intensity decreased immediately upon extracellular addition of the cell-membrane-permeable chelator TPEN (100 mM) at 15 min (Fig. 22d) . Clear images of intracellular Zn 2ϩ concentration changes were obtained with the TRLLM system (Fig. 22e) . To explore further the utility of TRLLM, we tested whether long-lived luminescence could be well distinguished from the short-lived fluorescence of rhodamine 6G as an artificial source of shortlived background fluorescence. Rhodamine 6G fluorescence directly interferes with Eu 3ϩ luminescence because rhodamine 6G has similar excitation and emission wavelength ranges to those of 9. We found that the time-resolved longlived luminescence images were not affected at all by rhodamine 6G fluorescence, i.e., 9 could be used to monitor changes of intracellular Zn 2ϩ concentration even in cells stained with rhodamine 6G (data not shown).
65)
Conclusion and Perspectives
Multi-modality molecular imaging is currently attracting much interest, because a single imaging modality can not provide complete information on targeted molecules. 44) For example, optical fluorescence imaging is difficult at more than a few millimeters in depth within a tissue specimen, and MRI has high resolution but low sensitivity. At presnt, combined MRI/optical imaging is one of the best-developed techniques of dual-modality imaging, and has been employed in biomedical research and clinical practice. 87) Indeed, MRI/optical probes have been increasingly developed in recent years. We have successfully designed and synthesized various responsive lanthanide-based MRI and luminescent probes for bioimaging. In the development of MRI contrast agents, effective strategies to increase or decrease the r 1 relaxivity include making use of increased hydration number, fast water exchange, slower molecular tumbling rate, and second-sphere effects. Therefore, through judicious molecular design, high-relaxivity complexes with highly targeted functions can be realized. However, responsive MRI contrast agents for monitoring biomolecules in vivo have only recently begun to appear in the literature, and only a few have been applied in vivo. Therefore, while advances in technology have made MR imaging a modality of choice, the development of highly sensitive and multipurpose MR contrast agents is still needed. For example, there have recently been advances in the design and synthesis of cell-penetrating and receptor-targeted MR imaging agents. [88] [89] [90] On the other hand, in the case of luminescent lanthanide complexes, sensors for a targeted analyte can be designed by rationally manipulating the parameters that influence the luminescence of lanthanide complexes, such as varying the number of innersphere water molecules, the distance separating the antenna from the lanthanide ion, the energies of excited states of the antenna, and PeT switches. Thus, a wide variety of analytes can be detected, including pH, ions, reactive oxygen species, and enzymes. 91) However, in designing luminescent lan- thanide sensors for cellular imaging, chemists should keep in mind that for practical applications, these complexes also must be able to penetrate cells. 5, 65, 92) Unfortunately, little is yet known about how lanthanide complexes penetrate cells. Until this problem is resolved, the practical utility of lanthanide complexes as intracellular probes will remain limited. Further, it is also necessary to develop sensors with a longer excitation wavelength in the visible region in order to reduce phototoxicity for biological applications. 93) Thus, the design of appropriate multi-modal imaging probes is the key to further advances in multi-modality bioimaging, and it may be particularly useful to develop MRI/optical multi-modal imaging probes. For example, compound 10, which is a homologue of 3, was relatively brightly luminescent (Fig. 23) , and the time-resolved luminescence spectra of 10 with a delay time of 50 ms displayed four bands (490, 545, 586, 622 nm), arising from transitions from the emissive 5 (Fig. 15) . 41) The Tb 3ϩ ion possesses the same charge as Gd 3ϩ , as well as similar ionic radius and coordination chemistry. Further, addition of b-galactosidase to an aqueous solution of 10 resulted in an about 43% decrease in the luminescence of Tb 3ϩ at 545 nm as shown in Fig. 24 . On the basis of the above results, the biphenyl substituent, which is an albumin-binding group, also serves as a sensitizing chromophore for Tb 3ϩ in the luminescent Tb 3ϩ complex 10, and a mixture of 3 and 10 could potentially be a multi-modal imaging probe. Thus, the development of multi-modal imaging probes for multi-modality molecular imaging certainly seems feasible, through the application of interdisciplinary approaches. 
